25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress

Litigation partner Meredith Auten and FDA and healthcare partner Scott Memmott will speak at the Pharmaceutical Compliance Forum’s 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress. The 2024 Pharma Congress will cover current topics addressing crucial ethics, compliance, and legal issues regarding pharmaceutical and medical devices.

Monday, October 28, 12:00–12:50 pm ET

Scott’s panel Enhancing Compliance and Overcoming Challenges under Corporate Integrity Agreement (CIA) through AI and Automation will provide practical insights into how AI and technology can transform the  compliance management landscape. He will be joined by the president of Epsilon Life Sciences, the head of US compliance at Biogen, and a principal consultant at Cresen Solutions.

Tuesday, October 29, 10:00–10:50 am ET

Meredith’s panel Best Practices in Investigations will cover key aspects of conducting investigations, collaborating on corrective and preventative measures, and aligning with management teams on key decisions based on the severity of policy violations. She will be joined by the CEO of Front-Line Anti-Bribery LLC and the health care compliance officer of global medical affairs and data science for Johnson & Johnson.